News

Soleno Therapeutics Added to Russell 3000® Index

June 29, 2020

REDWOOD CITY, Calif. , June 29, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares

June 26, 2020

REDWOOD CITY, Calif. , June 26, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics , Inc. (Nasdaq: SLNO), (“Soleno” or the “...

Read More

Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock

June 24, 2020

REDWOOD CITY, Calif. , June 24, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics , Inc. (Nasdaq:SLNO), (“Soleno” or the “...

Read More
Soleno – Home

Developing novel therapeutics for the treatment of rare diseases.

Pages

News and Events

Soleno Therapeutics Added to Russell 3000® Index

Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares

Contact Us

  • 203 Redwood Shores Parkway
  • Suite 500
  • Redwood City, CA 94065